Mevion Medical Systems

About:

Mevion Medical Systems develops radiation therapies for the treatment of cancer.

Website: http://www.mevion.com

Twitter/X: MevionMedical

Top Investors: Venrock, CHL Medical Partners, ProQuest Investments, Everbright, YuanMing Capital

Description:

Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality. Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide. Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.

Total Funding Amount:

$627M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Littleton, Massachusetts, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)mevion.com

Founders:

Kenneth Gall

Number of Employees:

101-250

Last Funding Date:

2018-06-14

IPO Status:

Private

© 2025 bioDAO.ai